| Primary |
| Product Used For Unknown Indication |
25.4% |
| Hypertension |
18.4% |
| Drug Use For Unknown Indication |
12.7% |
| Cardiac Failure Congestive |
6.7% |
| Cardiac Failure |
6.6% |
| Cardiac Failure Chronic |
6.0% |
| Oedema |
3.8% |
| Oedema Peripheral |
3.1% |
| Atrial Fibrillation |
2.9% |
| Type 2 Diabetes Mellitus |
2.6% |
| Diuretic Therapy |
2.3% |
| Fluid Retention |
1.6% |
| Diabetes Mellitus |
1.6% |
| Prophylaxis |
1.1% |
| Cardiac Failure Acute |
1.1% |
| Chronic Obstructive Pulmonary Disease |
1.0% |
| Coronary Artery Disease |
0.9% |
| Polyuria |
0.8% |
| Breast Cancer Metastatic |
0.8% |
| Depression |
0.8% |
|
| Renal Failure Acute |
27.9% |
| Syncope |
11.6% |
| Hypotension |
6.4% |
| Renal Failure |
5.4% |
| Hypokalaemia |
5.0% |
| Vomiting |
4.4% |
| Renal Impairment |
4.3% |
| Toxic Epidermal Necrolysis |
3.4% |
| Ventricular Tachycardia |
3.3% |
| Drug Ineffective |
3.2% |
| Somnolence |
3.2% |
| Hyponatraemia |
3.1% |
| Dehydration |
2.7% |
| Hyperkalaemia |
2.6% |
| Drug Interaction |
2.4% |
| Pemphigoid |
2.4% |
| Death |
2.3% |
| Presyncope |
2.2% |
| Electrocardiogram Qt Prolonged |
2.1% |
| Torsade De Pointes |
2.1% |
|
| Secondary |
| Product Used For Unknown Indication |
37.6% |
| Drug Use For Unknown Indication |
18.7% |
| Hypertension |
13.8% |
| Cardiac Failure |
4.6% |
| Atrial Fibrillation |
2.9% |
| Type 2 Diabetes Mellitus |
2.6% |
| Cardiac Failure Congestive |
2.1% |
| Diabetes Mellitus |
2.1% |
| Prophylaxis |
1.9% |
| Drug Abuse |
1.6% |
| Depression |
1.5% |
| Ill-defined Disorder |
1.5% |
| Oedema Peripheral |
1.3% |
| Pain |
1.3% |
| Cardiac Failure Chronic |
1.2% |
| Chronic Obstructive Pulmonary Disease |
1.2% |
| Coronary Artery Disease |
1.2% |
| Oedema |
1.1% |
| Pneumonia |
1.0% |
| Diuretic Therapy |
1.0% |
|
| Renal Failure Acute |
17.5% |
| Toxic Epidermal Necrolysis |
8.2% |
| Ventricular Tachycardia |
7.5% |
| Vomiting |
7.1% |
| Renal Failure |
6.9% |
| Completed Suicide |
6.1% |
| Hypotension |
4.9% |
| Syncope |
4.7% |
| Somnolence |
4.3% |
| Hallucination |
4.2% |
| Hyponatraemia |
4.1% |
| Death |
3.8% |
| Renal Impairment |
3.3% |
| Toxicity To Various Agents |
3.2% |
| Weight Decreased |
2.7% |
| Weight Increased |
2.5% |
| Drug Interaction |
2.4% |
| Hypokalaemia |
2.2% |
| Rhabdomyolysis |
2.2% |
| Torsade De Pointes |
2.2% |
|
| Concomitant |
| Product Used For Unknown Indication |
31.3% |
| Drug Use For Unknown Indication |
19.2% |
| Hypertension |
10.6% |
| Prophylaxis |
4.4% |
| Diabetes Mellitus |
3.8% |
| Pain |
3.7% |
| Atrial Fibrillation |
3.3% |
| Rheumatoid Arthritis |
3.1% |
| Cardiac Failure |
2.2% |
| Chronic Obstructive Pulmonary Disease |
2.2% |
| Depression |
1.9% |
| Cardiac Disorder |
1.9% |
| Type 2 Diabetes Mellitus |
1.9% |
| Multiple Myeloma |
1.7% |
| Pulmonary Arterial Hypertension |
1.6% |
| Osteoporosis |
1.6% |
| Constipation |
1.6% |
| Blood Cholesterol Increased |
1.5% |
| Gastrooesophageal Reflux Disease |
1.3% |
| Cardiac Failure Congestive |
1.2% |
|
| Vomiting |
11.6% |
| Weight Decreased |
8.2% |
| Weight Increased |
7.6% |
| Death |
7.6% |
| Renal Failure Acute |
6.2% |
| Pneumonia |
6.2% |
| Renal Failure |
5.5% |
| Urinary Tract Infection |
4.5% |
| Dyspnoea |
4.3% |
| Thrombocytopenia |
4.1% |
| Myocardial Infarction |
3.9% |
| Sepsis |
3.8% |
| Oedema Peripheral |
3.5% |
| Pyrexia |
3.5% |
| Nausea |
3.4% |
| Pain |
3.4% |
| Rhabdomyolysis |
3.3% |
| Drug Ineffective |
3.2% |
| Syncope |
3.1% |
| International Normalised Ratio Increased |
2.9% |
|
| Interacting |
| Drug Use For Unknown Indication |
20.2% |
| Hypertension |
19.9% |
| Product Used For Unknown Indication |
18.6% |
| Cardiac Failure |
8.9% |
| Atrial Fibrillation |
4.4% |
| Hepatic Cirrhosis |
4.4% |
| Ascites |
4.2% |
| Ill-defined Disorder |
2.3% |
| Prophylaxis |
2.2% |
| Diabetes Mellitus |
2.0% |
| Convulsion |
1.7% |
| Type 2 Diabetes Mellitus |
1.7% |
| Cardiac Disorder |
1.4% |
| Cardiac Failure Congestive |
1.3% |
| Coronary Artery Disease |
1.2% |
| Gastritis Prophylaxis |
1.1% |
| Oedema Peripheral |
1.1% |
| Cerebrovascular Accident |
1.1% |
| Hiv Infection |
1.1% |
| Right Ventricular Failure |
1.1% |
|
| Renal Failure Acute |
25.6% |
| Drug Interaction |
25.2% |
| Hepatic Encephalopathy |
6.4% |
| Renal Impairment |
5.1% |
| Hyperglycaemia |
3.4% |
| Hyperkalaemia |
3.0% |
| Renal Failure |
3.0% |
| Weight Increased |
3.0% |
| Hypotension |
2.6% |
| Syncope |
2.6% |
| Vomiting |
2.6% |
| Blood Creatinine Increased |
2.1% |
| Lactic Acidosis |
2.1% |
| Therapeutic Agent Toxicity |
2.1% |
| Toxicity To Various Agents |
2.1% |
| Tremor |
2.1% |
| Hyponatraemia |
1.7% |
| Oedema |
1.7% |
| Sepsis |
1.7% |
| Tibia Fracture |
1.7% |
|
